Entry |
|
Symbol |
PIK3CA, CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
Name |
(RefSeq) phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
KO |
K00922 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153] |
|
Organism |
|
Pathway |
hsa01521 | EGFR tyrosine kinase inhibitor resistance |
hsa04070 | Phosphatidylinositol signaling system |
hsa04072 | Phospholipase D signaling pathway |
hsa04213 | Longevity regulating pathway - multiple species |
hsa04550 | Signaling pathways regulating pluripotency of stem cells |
hsa04613 | Neutrophil extracellular trap formation |
hsa04620 | Toll-like receptor signaling pathway |
hsa04625 | C-type lectin receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa04664 | Fc epsilon RI signaling pathway |
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa04670 | Leukocyte transendothelial migration |
hsa04750 | Inflammatory mediator regulation of TRP channels |
hsa04810 | Regulation of actin cytoskeleton |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04919 | Thyroid hormone signaling pathway |
hsa04923 | Regulation of lipolysis in adipocytes |
hsa04932 | Non-alcoholic fatty liver disease |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa04960 | Aldosterone-regulated sodium reabsorption |
hsa04973 | Carbohydrate digestion and absorption |
hsa05100 | Bacterial invasion of epithelial cells |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
hsa05168 | Herpes simplex virus 1 infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
hsa05208 | Chemical carcinogenesis - reactive oxygen species |
hsa05230 | Central carbon metabolism in cancer |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
hsa05418 | Fluid shear stress and atherosclerosis |
|
Network |
|
Element |
N00030 | EGF-EGFR-RAS-PI3K signaling pathway |
N00031 | Duplication or mutation-activated FLT3 to RAS-PI3K signaling pathway |
N00032 | Mutation-activated KRAS/NRAS to PI3K signaling pathway |
N00033 | EGF-EGFR-PI3K signaling pathway |
N00034 | ERBB2-overexpression to PI3K signaling pathway |
N00035 | Amplified EGFR to PI3K signaling pathway |
N00036 | Mutation-activated EGFR to PI3K signaling pathway |
N00037 | FGF-FGFR-PI3K signaling pathway |
N00038 | Amplified FGFR to PI3K signaling pathway |
N00039 | PDGF-PDGFR-PI3K signaling pathway |
N00040 | Amplified PDGFR to PI3K signaling pathway |
N00042 | EGFR-overexpression to PI3K signaling pathway |
N00043 | HGF-MET-PI3K signaling pathway |
N00044 | Mutation-activated MET to PI3K signaling pathway |
N00045 | KITLG-KIT-PI3K signaling pathway |
N00046 | Mutation-activated KIT to PI3K signaling pathway |
N00047 | EML4-ALK fusion kinase to PI3K signaling pathway |
N00048 | BCR-ABL fusion kinase to PI3K signaling pathway |
N00049 | Mutation-activated PI3K to PI3K signaling pathway |
N00050 | Amplified PI3K to PI3K signaling pathway |
N00159 | KSHV K1 to PI3K signaling pathway |
N00179 | KSHV K1 to PI3K-NFKB signaling pathway |
N00182 | IGF-IGFR-PI3K-NFKB signaling pathway |
N00218 | FLT3LG-FLT3-RAS-PI3K signaling pathway |
N00231 | TGFA-EGFR-PI3K signaling pathway |
N00232 | TGFA-overexpression to PI3K signaling pathway |
N00234 | IGF2-IGF1R-PI3K signaling pathway |
N00236 | IGF2-overexpression to PI3K signaling pathway |
N00238 | IGF1R-overexpression to PI3K signaling pathway |
N00247 | HGF-overexpression to PI3K signaling pathway |
N00249 | MET-overexpression to PI3K signaling pathway |
N00253 | Amplified ERBB2 to PI3K signaling pathway |
N00260 | Amplified MET to PI3K signaling pathway |
N00266 | EBV LMP2A to PI3K signaling pathway |
N00267 | HBV HBx to PI3K signaling pathway |
N00272 | HCV NS5A to PI3K signaling pathway |
N00281 | EGF-overexpression to PI3K signaling pathway |
N00282 | EREG-EGFR-PI3K signaling pathway |
N00283 | EREG-overexpression to PI3K signaling pathway |
N00284 | AREG-EGFR-PI3K signaling pathway |
N00285 | AREG-overexpression to PI3K signaling pathway |
N00387 | HCMV IE1-72/IE2-86 to PI3K signaling pathway |
N00390 | EGF-EGFR-PI3K-NFKB signaling pathway |
N00399 | CCR2-GNB/G-PI3K-NFKB signaling pathway |
N00430 | CXCR4-GNAI-PI3K-BAD signaling pathway |
N00485 | EBV LMP1 to PI3K signaling pathway |
N00501 | HTLV-1 Tax to EGFR-PI3K-NFKB signaling pathway |
N00514 | Mutation-activated EGFR to PI3K signaling pathway |
N00582 | IGF-IGF1R-PI3K signaling pathway |
N00583 | HSV VP11/12 to PI3K signaling pathway |
N00683 | CD80/CD86-CD28-PI3K signaling pathway |
N00684 | MV F/H to CD28-PI3K signaling pathway |
N00736 | IAV NS1 to PI3K signaling pathway |
N00963 | RELN-VLDLR-PI3K signaling pathway |
N00964 | DAB1-overexpression to RELN-VLDLR-PI3K signaling pathway |
N01063 | Mutation-activated MET to PI3K signaling pathway |
N01065 | Mutation-activated RET to PI3K signaling pathway |
N01067 | Shigella IpgD to ARNO-ARF-ACTB_G signaling pathway |
N01129 | Salmonella SopB to ARNO-ARF-ACTB/G signaling pathway |
N01163 | NRG-ERBB4-PI3K signaling pathway |
N01204 | PRNP-PI3K-NOX2 signaling pathway |
N01205 | Scrapie conformation PrPSc to PRNP-PI3K-NOX2 signaling pathway |
N01338 | ACH-CHRN-PI3K signaling pathway |
N01339 | NNK/NNN to PI3K signaling pathway |
N01347 | EP/NE-ADRB-PI3K signaling pathway |
N01348 | Nicotine/NNK to PI3K signaling pathway |
N01349 | ACH-CHRN-PI3K signaling pathway |
N01350 | NNK/NNN to PI3K signaling pathway |
N01355 | Arsenic to PI3K signaling pathway |
N01356 | Membrane-initiated progesterone signaling pathway |
N01357 | P4/MPA to membrane-initiated progesterone signaling pathway |
N01358 | P4-PR-PI3K signaling pathway |
N01359 | P4/MPA to PR-PI3K signaling pathway |
N01656 | GF-RTK-PI3K signaling pathway |
N01658 | GF-RTK-RAS-PI3K signaling pathway |
N01708 | INS-AKT signaling pathway |
N01770 | CCR2-GNB/G-PI3K signaling pathway |
|
Disease |
H00014 | Non-small cell lung cancer |
H00048 | Hepatocellular carcinoma |
H00534 | Cerebral cavernous malformation |
H01912 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi |
H01985 | Desmoplastic small round cell tumor |
H02153 | Megalencephaly-capillary malformation syndrome |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
5290 (PIK3CA)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
5290 (PIK3CA)
04014 Ras signaling pathway
5290 (PIK3CA)
04015 Rap1 signaling pathway
5290 (PIK3CA)
04370 VEGF signaling pathway
5290 (PIK3CA)
04630 JAK-STAT signaling pathway
5290 (PIK3CA)
04668 TNF signaling pathway
5290 (PIK3CA)
04066 HIF-1 signaling pathway
5290 (PIK3CA)
04068 FoxO signaling pathway
5290 (PIK3CA)
04070 Phosphatidylinositol signaling system
5290 (PIK3CA)
04072 Phospholipase D signaling pathway
5290 (PIK3CA)
04071 Sphingolipid signaling pathway
5290 (PIK3CA)
04024 cAMP signaling pathway
5290 (PIK3CA)
04151 PI3K-Akt signaling pathway
5290 (PIK3CA)
04152 AMPK signaling pathway
5290 (PIK3CA)
04150 mTOR signaling pathway
5290 (PIK3CA)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
5290 (PIK3CA)
09143 Cell growth and death
04210 Apoptosis
5290 (PIK3CA)
04218 Cellular senescence
5290 (PIK3CA)
09144 Cellular community - eukaryotes
04510 Focal adhesion
5290 (PIK3CA)
04550 Signaling pathways regulating pluripotency of stem cells
5290 (PIK3CA)
09142 Cell motility
04810 Regulation of actin cytoskeleton
5290 (PIK3CA)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
5290 (PIK3CA)
04613 Neutrophil extracellular trap formation
5290 (PIK3CA)
04620 Toll-like receptor signaling pathway
5290 (PIK3CA)
04625 C-type lectin receptor signaling pathway
5290 (PIK3CA)
04650 Natural killer cell mediated cytotoxicity
5290 (PIK3CA)
04660 T cell receptor signaling pathway
5290 (PIK3CA)
04662 B cell receptor signaling pathway
5290 (PIK3CA)
04664 Fc epsilon RI signaling pathway
5290 (PIK3CA)
04666 Fc gamma R-mediated phagocytosis
5290 (PIK3CA)
04670 Leukocyte transendothelial migration
5290 (PIK3CA)
04062 Chemokine signaling pathway
5290 (PIK3CA)
09152 Endocrine system
04910 Insulin signaling pathway
5290 (PIK3CA)
04923 Regulation of lipolysis in adipocytes
5290 (PIK3CA)
04929 GnRH secretion
5290 (PIK3CA)
04915 Estrogen signaling pathway
5290 (PIK3CA)
04914 Progesterone-mediated oocyte maturation
5290 (PIK3CA)
04917 Prolactin signaling pathway
5290 (PIK3CA)
04926 Relaxin signaling pathway
5290 (PIK3CA)
04935 Growth hormone synthesis, secretion and action
5290 (PIK3CA)
04919 Thyroid hormone signaling pathway
5290 (PIK3CA)
09154 Digestive system
04973 Carbohydrate digestion and absorption
5290 (PIK3CA)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
5290 (PIK3CA)
09156 Nervous system
04725 Cholinergic synapse
5290 (PIK3CA)
04722 Neurotrophin signaling pathway
5290 (PIK3CA)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
5290 (PIK3CA)
09158 Development and regeneration
04360 Axon guidance
5290 (PIK3CA)
04380 Osteoclast differentiation
5290 (PIK3CA)
09149 Aging
04211 Longevity regulating pathway
5290 (PIK3CA)
04213 Longevity regulating pathway - multiple species
5290 (PIK3CA)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
5290 (PIK3CA)
05206 MicroRNAs in cancer
5290 (PIK3CA)
05205 Proteoglycans in cancer
5290 (PIK3CA)
05207 Chemical carcinogenesis - receptor activation
5290 (PIK3CA)
05208 Chemical carcinogenesis - reactive oxygen species
5290 (PIK3CA)
05203 Viral carcinogenesis
5290 (PIK3CA)
05230 Central carbon metabolism in cancer
5290 (PIK3CA)
05231 Choline metabolism in cancer
5290 (PIK3CA)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
5290 (PIK3CA)
09162 Cancer: specific types
05210 Colorectal cancer
5290 (PIK3CA)
05212 Pancreatic cancer
5290 (PIK3CA)
05225 Hepatocellular carcinoma
5290 (PIK3CA)
05226 Gastric cancer
5290 (PIK3CA)
05214 Glioma
5290 (PIK3CA)
05221 Acute myeloid leukemia
5290 (PIK3CA)
05220 Chronic myeloid leukemia
5290 (PIK3CA)
05218 Melanoma
5290 (PIK3CA)
05211 Renal cell carcinoma
5290 (PIK3CA)
05215 Prostate cancer
5290 (PIK3CA)
05213 Endometrial cancer
5290 (PIK3CA)
05224 Breast cancer
5290 (PIK3CA)
05222 Small cell lung cancer
5290 (PIK3CA)
05223 Non-small cell lung cancer
5290 (PIK3CA)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
5290 (PIK3CA)
05170 Human immunodeficiency virus 1 infection
5290 (PIK3CA)
05161 Hepatitis B
5290 (PIK3CA)
05160 Hepatitis C
5290 (PIK3CA)
05171 Coronavirus disease - COVID-19
5290 (PIK3CA)
05164 Influenza A
5290 (PIK3CA)
05162 Measles
5290 (PIK3CA)
05168 Herpes simplex virus 1 infection
5290 (PIK3CA)
05163 Human cytomegalovirus infection
5290 (PIK3CA)
05167 Kaposi sarcoma-associated herpesvirus infection
5290 (PIK3CA)
05169 Epstein-Barr virus infection
5290 (PIK3CA)
05165 Human papillomavirus infection
5290 (PIK3CA)
09171 Infectious disease: bacterial
05132 Salmonella infection
5290 (PIK3CA)
05131 Shigellosis
5290 (PIK3CA)
05135 Yersinia infection
5290 (PIK3CA)
05100 Bacterial invasion of epithelial cells
5290 (PIK3CA)
09174 Infectious disease: parasitic
05146 Amoebiasis
5290 (PIK3CA)
05142 Chagas disease
5290 (PIK3CA)
09164 Neurodegenerative disease
05010 Alzheimer disease
5290 (PIK3CA)
05017 Spinocerebellar ataxia
5290 (PIK3CA)
05020 Prion disease
5290 (PIK3CA)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
5290 (PIK3CA)
05418 Fluid shear stress and atherosclerosis
5290 (PIK3CA)
05415 Diabetic cardiomyopathy
5290 (PIK3CA)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
5290 (PIK3CA)
04932 Non-alcoholic fatty liver disease
5290 (PIK3CA)
04931 Insulin resistance
5290 (PIK3CA)
04933 AGE-RAGE signaling pathway in diabetic complications
5290 (PIK3CA)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
5290 (PIK3CA)
01524 Platinum drug resistance
5290 (PIK3CA)
01522 Endocrine resistance
5290 (PIK3CA)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:hsa04131]
5290 (PIK3CA)
Enzymes [BR:hsa01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.1 Phosphotransferases with an alcohol group as acceptor
2.7.1.153 phosphatidylinositol-4,5-bisphosphate 3-kinase
5290 (PIK3CA)
Membrane trafficking [BR:hsa04131]
Endocytosis
Rab GTPases and associated proteins
Rab associated proteins
5290 (PIK3CA)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
LinkDB |
|
Position |
3:179148126..179240093
|
AA seq |
1068 aa
MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQ
LLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFA
IGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKH
IYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLK
LCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMD
CFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGI
YHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHC
PLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWF
SSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPL
SEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAME
LLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTN
QRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILK
QEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLW
LNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLS
IGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRS
CAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDF
LIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIA
YIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN |
NT seq |
3207 nt +upstreamnt +downstreamnt
atgcctccacgaccatcatcaggtgaactgtggggcatccacttgatgcccccaagaatc
ctagtagaatgtttactaccaaatggaatgatagtgactttagaatgcctccgtgaggct
acattaataaccataaagcatgaactatttaaagaagcaagaaaataccccctccatcaa
cttcttcaagatgaatcttcttacattttcgtaagtgttactcaagaagcagaaagggaa
gaattttttgatgaaacaagacgactttgtgaccttcggctttttcaaccctttttaaaa
gtaattgaaccagtaggcaaccgtgaagaaaagatcctcaatcgagaaattggttttgct
atcggcatgccagtgtgtgaatttgatatggttaaagatccagaagtacaggacttccga
agaaatattctgaacgtttgtaaagaagctgtggatcttagggacctcaattcacctcat
agtagagcaatgtatgtctatcctccaaatgtagaatcttcaccagaattgccaaagcac
atatataataaattagataaagggcaaataatagtggtgatctgggtaatagtttctcca
aataatgacaagcagaagtatactctgaaaatcaaccatgactgtgtaccagaacaagta
attgctgaagcaatcaggaaaaaaactcgaagtatgttgctatcctctgaacaactaaaa
ctctgtgttttagaatatcagggcaagtatattttaaaagtgtgtggatgtgatgaatac
ttcctagaaaaatatcctctgagtcagtataagtatataagaagctgtataatgcttggg
aggatgcccaatttgatgttgatggctaaagaaagcctttattctcaactgccaatggac
tgttttacaatgccatcttattccagacgcatttccacagctacaccatatatgaatgga
gaaacatctacaaaatccctttgggttataaatagtgcactcagaataaaaattctttgt
gcaacctacgtgaatgtaaatattcgagacattgataagatctatgttcgaacaggtatc
taccatggaggagaacccttatgtgacaatgtgaacactcaaagagtaccttgttccaat
cccaggtggaatgaatggctgaattatgatatatacattcctgatcttcctcgtgctgct
cgactttgcctttccatttgctctgttaaaggccgaaagggtgctaaagaggaacactgt
ccattggcatggggaaatataaacttgtttgattacacagacactctagtatctggaaaa
atggctttgaatctttggccagtacctcatggattagaagatttgctgaaccctattggt
gttactggatcaaatccaaataaagaaactccatgcttagagttggagtttgactggttc
agcagtgtggtaaagttcccagatatgtcagtgattgaagagcatgccaattggtctgta
tcccgagaagcaggatttagctattcccacgcaggactgagtaacagactagctagagac
aatgaattaagggaaaatgacaaagaacagctcaaagcaatttctacacgagatcctctc
tctgaaatcactgagcaggagaaagattttctatggagtcacagacactattgtgtaact
atccccgaaattctacccaaattgcttctgtctgttaaatggaattctagagatgaagta
gcccagatgtattgcttggtaaaagattggcctccaatcaaacctgaacaggctatggaa
cttctggactgtaattacccagatcctatggttcgaggttttgctgttcggtgcttggaa
aaatatttaacagatgacaaactttctcagtatttaattcagctagtacaggtcctaaaa
tatgaacaatatttggataacttgcttgtgagatttttactgaagaaagcattgactaat
caaaggattgggcactttttcttttggcatttaaaatctgagatgcacaataaaacagtt
agccagaggtttggcctgcttttggagtcctattgtcgtgcatgtgggatgtatttgaag
cacctgaataggcaagtcgaggcaatggaaaagctcattaacttaactgacattctcaaa
caggagaagaaggatgaaacacaaaaggtacagatgaagtttttagttgagcaaatgagg
cgaccagatttcatggatgctctacagggctttctgtctcctctaaaccctgctcatcaa
ctaggaaacctcaggcttgaagagtgtcgaattatgtcctctgcaaaaaggccactgtgg
ttgaattgggagaacccagacatcatgtcagagttactgtttcagaacaatgagatcatc
tttaaaaatggggatgatttacggcaagatatgctaacacttcaaattattcgtattatg
gaaaatatctggcaaaatcaaggtcttgatcttcgaatgttaccttatggttgtctgtca
atcggtgactgtgtgggacttattgaggtggtgcgaaattctcacactattatgcaaatt
cagtgcaaaggcggcttgaaaggtgcactgcagttcaacagccacacactacatcagtgg
ctcaaagacaagaacaaaggagaaatatatgatgcagccattgacctgtttacacgttca
tgtgctggatactgtgtagctaccttcattttgggaattggagatcgtcacaatagtaac
atcatggtgaaagacgatggacaactgtttcatatagattttggacactttttggatcac
aagaagaaaaaatttggttataaacgagaacgtgtgccatttgttttgacacaggatttc
ttaatagtgattagtaaaggagcccaagaatgcacaaagacaagagaatttgagaggttt
caggagatgtgttacaaggcttatctagctattcgacagcatgccaatctcttcataaat
cttttctcaatgatgcttggctctggaatgccagaactacaatcttttgatgacattgca
tacattcgaaagaccctagccttagataaaactgagcaagaggctttggagtatttcatg
aaacaaatgaatgatgcacatcatggtggctggacaacaaaaatggattggatcttccac
acaattaaacagcatgcattgaactga |